GlycoMimetics Announces Preclinical Data Shows GMI-1271 Reverses Drug Resistance in Multiple Myeloma Models at #ASH15
December 05, 2015 at 10:16 AM EST
GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that preclinical data presented in a poster at the 57th American ...
